IMSN Covid-19 Vaccine Safety Interest Group (CVSIG )

Click on the titles to access the content

IMSN CVSIG Charter

  • IMSN Covid-19 Vaccine Safety Interest Group Charter Read on…

IMSN CVSIG List of participants

CountryOrganizationContact
BrazilInstituto para Práticas Seguras no Uso de Medicamentos (ISMP-Brasil)Mario Borges
CanadaInstitute for Safe Medication Practices Canada (ISMP-Canada)David U (temporary)
CanadaInstitute for Safe Medication Practices Canada (ISMP-Canada)Dorothy Tscheng
CanadaHealth CanadaSally Pepper
CanadaHealth CanadaJhona Rose
ColombiaColombian Society of Hospital Pharmacists (ACQFH)Ismael Basto
ColombiaColombian Society of Hospital Pharmacists (ACQFH)Juan Pablo Osorio
European UnionEuropean Medicines Agency (EMA)Alexios Skarlatos
FranceFrench Network of Pharmacovigilance CentersMarie-Blanche Rabier
FrancePrescrire' Preventing the Preventable ProgrammeEtienne Schmitt 
GermanyHead of the Hospital Pharmacy of Heidelberg University HospitalTorsten Hoppe-Tichy
GermanyDrug Commission of the German Medical Association (AkdÄ)Birgit Vogt
Hong KongHospital Authority Chief PharmacistBenjamin Lee
IrelandHealth Service ExecutiveMuriel Pate
IrelandIrish Medication Safety NetworkNiamh O’Hanlon
ISOPChair of the ISOP Medication Errors GroupBrian Edwards
ISOPCo-Chair of the ISOP Medication Errors GroupAngela Cora
MoroccoMorocco Poison Control and Pharmacovigilance Centre (CAPM)Ghita Benabdallah
MoroccoMorocco Poison Control and Pharmacovigilance Centre (CAPM)Houda Sefiani
NetherlandsInstituut Verantwoord Medicijngebruik - Voorkomen Medicatie-Incidenten (VMI)Jaap Dik
NetherlandsInstituut Verantwoord Medicijngebruik - Voorkomen Medicatie-Incidenten (VMI)Rob Essink
New ZealandNew Zealand Pharmacovigilance CentreMichael Tatley
NorwayNorway Medicine AgencySigurd Hortemo
Saudi ArabiaSaudi Medication Safety CenterHind Modaimegh
SingaporeChairperson of the National Medication Safety CommitteeAugustine Tse
SpainInstituto para el Uso Seguro de los Medicamentos (ISMP-España)Maria Jose Otero
UAEEmirates Pharmaceutical SocietySohail Fitieh
UKMedicines and Healthcare products Regulatory Agency (MHRA)Mitul Jadeja
UKNational Health Service (NHS)Jennie Hall
UMCUppsala Monitoring Centre (UMC)Alem Zekarias
USAInstitute for Safe Medication Practices ISMPChristina Michalek
USAInstitute for Safe Medication Practices ISMPMike Cohen
USAInstitute for Safe Medication Practices ISMPRita Jew
USAInternational Medication Safety Management FellowJill Paslier
USAInternational Medication Safety Management FellowMerissa Andersen
USAUS Food & Drug Administration FDALubna Merchant
USAVaccine DynamicsJohn Grabenstein
WHOPharmacovigilance (PVG), as observerAyako Fukishima

February 11, 2021 CVSIG meeting

,

March 11, 2021 CVSIG meeting

  • Agenda
  • Minutes,
    taken by Jill Paslier, ISMP International Medication Safety Management Fellow
  • Chat transcript
  • France approach to COVID-19 vaccinations – Marie-Blanche Valnet-Rabier Read on…
  • Ireland approach to COVID-19 vaccinations – Niamh O’Hanlon Read on…
  • US approach to COVID-19 vaccinations – Michael Cohen Read on…

April 8, 2021 CVSIG meeting

  • Agenda
  • Minutes,
    taken by Jill Paslier, ISMP International Medication Safety Management Fellow
  • Chat transcript
  • The Canadian experience – ISMP Canada and Health Canada; Sally Pepper Read on…
  • The Norwegian experience – Sigurd Hortemo Read on…
  • An update from Uppsala Monitoring Centre – Alem Zekarias Read on…
  • CVSIG survey review by ISMP Fellows - Merissa Andersen and Jill Paslier Read on…

May 6, 2021 CVSIG meeting

June 3, 2021 CVSIG meeting

  • Agenda
  • Minutes,
    taken by Jill Paslier, ISMP International Medication Safety Management Fellow
  • Comments on The Morocco experience – Dr. Ghita Benabdallah Read on…
  • The Saudi Arabia experience – Dr. Hind Almodaimegh Read on…
  • Covid-19 Vaccines International Nonproprietary Names (INN) - Dr Raffaella Balocco Mattavelli, World Health Organization. Oral presentation with reference to Loizides U, Adisa A, López de la Rica Manjavacas A, et al. WHO international non-proprietary names: the need to distinguish COVID-19 vaccines. Lancet 2021; 397 (10274): 577-578. Read on…

July 15, 2021 CVSIG meeting

  • Agenda: development of a guidance document
  • Minutes,
    taken by Merissa Andersen, ISMP International Medication Safety Management Fellow